Sabra Health Care Reit Inc Stock Price, News & Analysis

Sabra Health Care REIT, Inc. (Nasdaq: SBRA) will release its third quarter earnings for 2022 on November 7, 2022, after market close. A conference call will follow on November 8 at 10:00 a.m. Pacific Time to discuss the results. Investors can access the webcast through a designated URL and participate via telephone following prior registration. Sabra operates as a self-managed REIT focusing on real estate for the healthcare sector in the U.S. and Canada.

Sabra Health Care REIT (NASDAQ: SBRA) announced participation in two upcoming conferences. CEO Rick Matros, CFO Michael Costa, and SVP Lukas Hartwich will attend the BofA Securities 2022 Global Real Estate Conference on September 13-14, 2022, in New York City. Additionally, Chief Investment Officer Talya Nevo-Hacohen and EVP Darrin Smith will participate in the NIC Fall Conference from September 14-16, 2022, in Washington, D.C. Sabra operates as a self-administered and self-managed REIT focused on the healthcare sector in the U.S. and Canada.

Sabra Health Care REIT (NASDAQ: SBRA) announced that its CEO, Rick Matros, will participate as a panelist at the Skilled Nursing News’ RETHINK Conference on September 1, 2022, in Chicago, Illinois. The event focuses on innovations and strategies in the skilled nursing sector.

Sabra operates as a self-administered, self-managed real estate investment trust (REIT), investing in healthcare-related real estate across the U.S. and Canada, aiming to enhance care services within the industry.

Sabra Health Care REIT, Inc. (NASDAQ: SBRA) announced that Talya Nevo-Hacohen, Chief Investment Officer, will attend the SafelyYou Inaugural Silicon Valley Senior Living Summit from August 29-31, 2022. She will participate in the Capital Partner panel on August 30, 2022, at the Rosewood Sand Hill hotel in Menlo Park, California. Sabra Health Care REIT operates as a self-managed real estate investment trust, focusing on healthcare-related properties in the U.S. and Canada.

Sabra Health Care REIT (Nasdaq: SBRA) reported Q2 2022 results, with net income of $0.07 and FFO of $0.36 per share. The company acquired 12 Canadian senior housing communities for $147.4 million, with a stabilized cash yield of 6.5%. Sabra also generated $40.2 million from the sale of eight facilities, with additional sales expected to yield over $210 million. The Board declared a $0.30 dividend, representing 79% of Normalized AFFO. Total liquidity as of June 30, 2022, was approximately $924.8 million. The company aims to reach a 5.0x net debt to adjusted EBITDA ratio by year-end.

Sabra Health Care REIT, Inc. (NASDAQ: SBRA) will release its 2022 second quarter earnings on August 3, 2022, after market close. A conference call to discuss the results is scheduled for August 4, 2022, at 10:00 a.m. PT. Investors can access the call via a unique PIN after registration. A digital replay will be available on their website. Sabra operates as a self-administered REIT, focusing on healthcare real estate investments across the U.S. and Canada.

Sabra Health Care REIT (NASDAQ: SBRA) announced participation in Nareit's REITweek 2022 Investor Conference, taking place from June 7-9, 2022 at the New York Hilton Midtown. Key executives attending include Rick Matros (Chair & CEO), Michael Costa (CFO), Talya Nevo-Hacohen (CIO), and Lukas Hartwich (SVP of Finance). Sabra focuses on real estate investments in the healthcare sector across the U.S. and Canada.

Sabra Health Care REIT, Inc. (NASDAQ: SBRA) has completed the acquisition of a high-quality Canadian senior housing portfolio for C$307.5 million (USD $236.5 million) through a 50/50 joint venture with Sienna Senior Living (TSX: SIA). This portfolio includes 11 independent living communities located in Ontario and Saskatchewan, with an average age of six years. The acquisition positions Sabra to benefit from the anticipated demand growth as Canada's 75+ population is projected to double in the next 20 years. Funding for this acquisition was sourced from cash reserves and a credit facility.